Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

BioSpecifics Technologies announces positive preliminary results in Peyronie's disease therapy

Aug. 11, 1999

Mochida presents potent and selective heterocyclic cGMP-PDE inhibitors

July 30, 1999

NS-49: preclinical pharmacokinetics of potential new agent for stress incontinence

July 28, 1999

Rochester Medical's female incontinence device receives CE mark

July 28, 1999

Nitrosylated alpha-adrenoceptor antagonists as potential agents for impotence

July 27, 1999

Alza expands promotion of Ditropan XL for overactive bladder

July 27, 1999

Z-350, a novel treatment for BPH with a dual mechanism of action

July 21, 1999

Potential new diuretic agents selected for detailed biological evaluation at Wakamoto

July 16, 1999

Recently issued patent covers Sanofi-Synthelabo's new M3 antagonists

July 16, 1999

Nephrin plays a key role in kidney filtration

July 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...